1,634 Shares in HCA Healthcare, Inc. $HCA Acquired by Storgate LLC

Storgate LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,634 shares of the company’s stock, valued at approximately $763,000. HCA Healthcare accounts for 0.6% of Storgate LLC’s investment portfolio, making the stock its 24th largest position.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sumitomo Life Insurance Co. raised its holdings in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares during the period. MJP Associates Inc. ADV increased its holdings in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares during the period. Cary Street Partners Financial LLC increased its holdings in shares of HCA Healthcare by 3.9% during the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after purchasing an additional 22 shares during the period. Finally, Plato Investment Management Ltd increased its holdings in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after purchasing an additional 22 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 2.3%

Shares of HCA stock opened at $387.25 on Friday. The firm has a market capitalization of $85.91 billion, a price-to-earnings ratio of 13.32, a PEG ratio of 1.20 and a beta of 1.12. The firm’s 50 day moving average is $429.60 and its 200-day moving average is $473.48. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is 10.73%.

Analyst Ratings Changes

HCA has been the topic of several research reports. JPMorgan Chase & Co. dropped their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Wells Fargo & Company dropped their price objective on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Robert W. Baird decreased their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Mizuho upped their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Finally, Oppenheimer lowered their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $506.14.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.